BE1028307B1 - Complementary animal feeds including GABA, 5-HTP and targeted cofactors - Google Patents
Complementary animal feeds including GABA, 5-HTP and targeted cofactorsInfo
- Publication number
- BE1028307B1 BE1028307B1 BE20200060A BE202000060A BE1028307B1 BE 1028307 B1 BE1028307 B1 BE 1028307B1 BE 20200060 A BE20200060 A BE 20200060A BE 202000060 A BE202000060 A BE 202000060A BE 1028307 B1 BE1028307 B1 BE 1028307B1
- Authority
- BE
- Belgium
- Prior art keywords
- cofactors
- htp
- gaba
- targeted
- animal feeds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Abstract
La présente invention se rapporte à une formulation sous forme d'aliments complémentaires à destination animale, sous forme de cachets, gélules, granulés, liquide (à diluer ou boisson prête à l'emploi) ou aliments supplémentés, comprenant du GABA et/ou associé à du 5-HTP en plus des cofacteurs : Arginine, Magnésium et Vitamine B6, un arôme appétant pour l'espèce de destination et contenant des excipients techniques tels qu'un sucre, un agglomérant ou tout autre excipient technique utile à son intégrité. Les composés GABA et cofacteurs, et, 5-HTP et cofacteurs sont présentés séparément, mais peuvent être administrés simultanément afin de traiter les troubles du comportement animal.The present invention relates to a formulation in the form of complementary foods for animals, in the form of cachets, capsules, granules, liquid (to be diluted or ready-to-use drink) or supplemented foods, comprising GABA and/or associated with 5-HTP in addition to the cofactors: Arginine, Magnesium and Vitamin B6, an aroma that is palatable for the species of destination and containing technical excipients such as a sugar, a binder or any other technical excipient useful for its integrity. The compounds GABA and cofactors, and 5-HTP and cofactors are presented separately, but can be administered simultaneously in order to treat animal behavioral disorders.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20200060A BE1028307B9 (en) | 2020-05-14 | 2020-05-14 | Complementary animal feeds including GABA, 5-HTP and targeted cofactors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20200060A BE1028307B9 (en) | 2020-05-14 | 2020-05-14 | Complementary animal feeds including GABA, 5-HTP and targeted cofactors |
Publications (4)
Publication Number | Publication Date |
---|---|
BE1028307A1 BE1028307A1 (en) | 2021-12-09 |
BE1028307B1 true BE1028307B1 (en) | 2022-02-15 |
BE1028307A9 BE1028307A9 (en) | 2022-03-08 |
BE1028307B9 BE1028307B9 (en) | 2022-03-14 |
Family
ID=75728527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE20200060A BE1028307B9 (en) | 2020-05-14 | 2020-05-14 | Complementary animal feeds including GABA, 5-HTP and targeted cofactors |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE1028307B9 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681578A (en) * | 1996-01-22 | 1997-10-28 | Sahley; Billie J. | Composition for relieving stress anxiety, grief, and depression |
US6068846A (en) * | 1998-08-05 | 2000-05-30 | Melaleuca, Incorporated | Methods and materials for treating depression and mood disorder |
US20050106220A1 (en) * | 2003-10-29 | 2005-05-19 | Kentaro Inagawa | Agent for improving mobility and general health of senior companion animals |
US20050191341A1 (en) * | 2004-03-01 | 2005-09-01 | Gottfried Kellermann | Liposomal composition comprising L-theanine |
WO2015066009A1 (en) * | 2013-10-29 | 2015-05-07 | Mars, Inc. | Dry pet food comprising a palatability enhancing coating |
WO2015153499A1 (en) * | 2014-03-29 | 2015-10-08 | Innophos, Inc. | Pet food palatant composition comprising mixed alkali metal pyrophosphates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20041689A1 (en) | 2004-09-01 | 2004-12-02 | Bojidar Mihaylov Stankov | NEW FORMULATIONS OF CONTROLLED RELEASE CONTAINING 5-HYDROXYTYRIPHOPHANE AND TRIPTOPHAN |
-
2020
- 2020-05-14 BE BE20200060A patent/BE1028307B9/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681578A (en) * | 1996-01-22 | 1997-10-28 | Sahley; Billie J. | Composition for relieving stress anxiety, grief, and depression |
US6068846A (en) * | 1998-08-05 | 2000-05-30 | Melaleuca, Incorporated | Methods and materials for treating depression and mood disorder |
US20050106220A1 (en) * | 2003-10-29 | 2005-05-19 | Kentaro Inagawa | Agent for improving mobility and general health of senior companion animals |
US20050191341A1 (en) * | 2004-03-01 | 2005-09-01 | Gottfried Kellermann | Liposomal composition comprising L-theanine |
WO2015066009A1 (en) * | 2013-10-29 | 2015-05-07 | Mars, Inc. | Dry pet food comprising a palatability enhancing coating |
WO2015153499A1 (en) * | 2014-03-29 | 2015-10-08 | Innophos, Inc. | Pet food palatant composition comprising mixed alkali metal pyrophosphates |
Also Published As
Publication number | Publication date |
---|---|
BE1028307B9 (en) | 2022-03-14 |
BE1028307A9 (en) | 2022-03-08 |
BE1028307A1 (en) | 2021-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3773528B1 (en) | Hemp extract for treatment of pain in animals | |
Medeiros et al. | Tremorgenic syndrome in goats caused by Ipomoea asarifolia in Northeastern Brazil | |
MA27710A1 (en) | PALONOSETRONE LIQUID PHARMACEUTICAL FORMULATIONS | |
MA29681B1 (en) | GALENIC FORMS OF RISEDRONATE | |
JP6095549B2 (en) | Composition containing riboflavin and sesamin | |
JPWO2008149994A1 (en) | Ruminant bloating control agent | |
Patel et al. | Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects | |
MA38688A1 (en) | Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d | |
MA37317B1 (en) | Antibody formulation il-17 | |
Chandran et al. | Supplemental calcium intake in the aging individual: implications on skeletal and cardiovascular health | |
TWI440458B (en) | Containing sesamin and arachidonic acid | |
WO2010053085A1 (en) | Agent for preventing acidosis in ruminant animals | |
BE1028307B1 (en) | Complementary animal feeds including GABA, 5-HTP and targeted cofactors | |
US20200397905A1 (en) | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents | |
Giorgi | CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients | |
WO2019059246A1 (en) | Composition for preventing or ameliorating hand-foot syndrome | |
CN105764499A (en) | Soft capsule containing DHA and EPA | |
Moraes et al. | Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol | |
MA41102A (en) | COMPOSITIONS CONTAINING CURCUMIN WITH ENHANCED BIOAVAILABILITY | |
WO2019016988A1 (en) | Composition | |
WO2021112217A1 (en) | Composition for suppressing increase in amount of neutral fat in liver | |
JP6981311B2 (en) | Composition for improving anxiety-like symptoms | |
NL2015506B1 (en) | Oral administration of Vitamin B12 dispersed in a hydrophobic continuous phase | |
Abdelmissih | Perspective Chapter: Neurotoxins and Erythrocytes–A Double-headed Arrow | |
JP2008024675A (en) | Liquid composition for internal medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Effective date: 20220215 |
|
MM | Lapsed because of non-payment of the annual fee |
Effective date: 20220531 |